Many cannabis stocks are incredibly overvalued so it can be difficult to determine which cannabis companies to invest in. If you invest as I do, you’re probably seeking solid buy and hold stocks which will hopefully appreciate 5-10x within the next few years. Enter Aphria (NYSE: APHA).
Aphria is on an absolute tear this year and currently up about 80%. Aphria’s current price target is nearly $16/share and as of 10:22am MST the stock is trading at $9.20/share. If you picked up a couple hundred shares today, you stand to make a solid short-term profit.
But why buy now?
- Well, Aphria is on track to produce over 250,000 KG of cannabis per year – securing a production foothold right behind the premier cannabis industry darlings Aurora Cannabis (ACB) and Canopy Growth Corp. (CGC).
- In addition, Aphria has supply agreements with all 10 Canadian provinces and a super healthy international presence in Germany, South America, Australia, and others.
- Until now, Aphria’s production capacity has stagnated – but Health Canada’s recent approval of the Aphria One Facility will change that.
- Past controversies have determined the stock price which is why it continues to underperform compared to its peers but with a new CEO and new independent members of the board – things seem to be looking up for the company.
If you’re an aggressive investor like me – and looking for a company on a solid trajectory, you’ll consider picking some shares up today.
As Buffet says, “[Be] fearful when others are greedy and greedy when others are fearful.”
Aphria Inc., one of Canada’s lowest cost producers, produces, supplies and sells medical cannabis. Located in Leamington, Ontario, the greenhouse capital of Canada, Aphria is truly powered by sunlight allowing for the most natural growing conditions available. Aphria is committed to providing pharma-grade medical cannabis, superior patient care while balancing patient economics and returns to shareholders.
Aphria is ‘truly powered by sunlight’, allowing for the most natural growing conditions available to produce safe medical cannabis products. They are 100% greenhouse grown under strict, consistent standards and have a devoted Patient Care Team to assist their clients.
For more information, visit: aphria.ca
Interested in other cannabis companies? Looking to diversify in cannabis? We love Organigram (OTC: OGRMF) for many reasons. See why we think this stock is even better than Aphria.
Hell, if you had taken our advice and purchased shares in Organigram back in January – you would have doubled your money by now!
Curious how to learn about and invest in cannabis companies? Sign up for Cannin Free Access.